Spanish Red Biotech Pipeline

MSD

Pembrolizumab/Lenvatinib

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pemetrexed + Platinum Chemotherapy + Pembrolizumab with or without Lenvatinib in first line (1L) metastatic non-squamous NSCLC
Phase: 3Phase III in Spain, 2Phase II, 1Phase I